Loading
institutionsInstitution
Hospital de Clínicas de Porto Alegre
Southern Brazil's leading public university hospital, known for cancer genetics, Li-Fraumeni research and one of Brazil's strongest clinical research programmes.
Also called: HCPA
Overview
Hospital de Clínicas de Porto Alegre opened in 1971 as the teaching hospital of the Universidade Federal do Rio Grande do Sul and is one of Brazil's top public research hospitals and a designated high-complexity oncology centre. Its oncology and medical genetics services, under Patricia Ashton-Prolla and colleagues, characterised the high prevalence of the TP53 R337H founder mutation in southern Brazil and built hereditary cancer clinics and registries, and its haematology, paediatric oncology, breast and gastrointestinal cancer programmes contribute to Latin American and international cooperative trials, including through the Latin American Cooperative Oncology Group (LACOG) headquartered in Porto Alegre. HCPA runs a large clinical research centre and a radiotherapy and bone marrow transplant service for the public system.
Location
Porto Alegre, BR
Type
hospital · Universidade Federal do Rio Grande do Sul
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#299 · 22 points (0 Newsweek + 0 NCI + 22 from 11 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-10-01.
Matched to Hospital de Clínicas de Porto Alegre, including child institutions. 130 works · 2,173 citations · 75% open access · 10% clinical trials · 5% reviews.
Oncology works per year
252022
342023
252024
312025
152026
Most works
- Renato Marchiori Bakos10 works
- Patrícia Ashton‐Prolla8 works
- Harald Kittler5 works
- Pedro Emanuel Rubini Liedke5 works
- Daniela Dornelles Rosa5 works
- Josep Malvehy5 works
- Aimilios Lallas5 works
- Giuseppe Argenziano5 works
- Susana Puig5 works
- Luc Thomas5 works
Most cited
- Hereditary cancer and Li-Fraumeni research
- Clinical research centre
- Haematology and transplant
- LACOG collaboration
Brasil Silva Neto
President
UrologyUro-oncologyHospital leadership
Urologist who has served as President of Hospital de Clínicas de Porto Alegre, a leading Brazilian university hospital, since 2024.
Carlos Barrios
Medical oncologist; Director, Oncology Research Center, Hospital São Lucas PUCRS; Latin American Cooperative Oncology Group
Breast cancerClinical trials in Latin AmericaGlobal oncology
Carlos Barrios is the most visible Latin American voice in global breast cancer trials and a founder of the region's cooperative group LACOG.
Similar pages
- InstitutionA.C. Camargo Cancer Center
Shares Li-Fraumeni syndrome (germline TP53), Hereditary cancer syndromes, Germline (hereditary) testing, TP53.
- CollectionFORCE: Facing Our Risk of Cancer Empowered
Shares Hereditary cancer syndromes, BRCA1 / BRCA2 (HRD), Germline (hereditary) testing.
- InstitutionUniversity of Malaya Medical Centre
Shares BRCA1 / BRCA2 (HRD), Germline (hereditary) testing, HR-positive / HER2-negative breast cancer, Colorectal cancer.
- InstitutionRamathibodi Hospital, Mahidol University
Shares Germline (hereditary) testing, Acute lymphoblastic leukaemia, HR-positive / HER2-negative breast cancer, Colorectal cancer.
- Key paperInherited breast cancer in Nigerian women
Shares BRCA1 / BRCA2 (HRD), Germline (hereditary) testing, TP53.
- JournalFamilial cancer
Shares Hereditary cancer syndromes, Germline (hereditary) testing.
- CollectionNHS Jewish BRCA Testing Programme
Shares Hereditary cancer syndromes, BRCA1 / BRCA2 (HRD), Germline (hereditary) testing, Prostate cancer.
- InstitutionInstituto Português de Oncologia do Porto Francisco Gentil
Shares BRCA1 / BRCA2 (HRD), Germline (hereditary) testing, HR-positive / HER2-negative breast cancer, Prostate cancer.